StottR.B., CameronJ.S., OggC.S., BewickM.. Why the persistently high mortality in acute renal failure.Lancet1972; 2(767): 75–9.
8.
TurneyJ.H.. Outcome in acute renal failure. In: RaineA.E.G., ed. Advanced renal medicine.Oxford: Oxford University Press, 1992: 314–24.
9.
EvansonJ.A., HakimR.M., WingardR.L.. Assessment of dose of dialysis in acute renal failure (ARF) patients.J Am Soc Nephrol1996; 7: 1512 (abstract).
10.
PaganiniE.P., TapolyaiM., GoormasticM.. Establishing a dialysis therapy patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis.Nov1996; 28(5): S81–9.
11.
GillumD.M., DixonB.S., YanoverM.J.. The role of intensive dialysis in acute renal failure.Clin Nephrol1986; 25(5): 249–55.
12.
HörlW.H., SchaeferR.M., HörlM.. Neutrophil activation in acute renal failure and sepsis.Arch Surg1990; 125: 651–4.
13.
WradleE.N.. Acute renal failure and multiorgan failure.Nephron1994; 66: 380–5.
14.
VanholderR., LameireN., HosteE., Van LooA., DhondtA.M., RingoirS.. Different types of dialyzer membranes: does the bio(in)compatibility matter in the treatment of ARF?Ren Fail1996; 18(3): 471–9.
15.
BloembergenH.E., PortF.K., HakimR.M.. The relationship of dialysis membranes and cause-specific mortality in chronic hemodialysis patients.JASN1995; 6: 521.
16.
BloembergenW.E., StannardD.C., PortF.K.. Relationship of dose of hemodialysis and cause-specific mortality.Kidney Int1996; 50: 557–65.
17.
LevinN.W., ZasuwaG., DumlerF.. Effect of membrane types on causes of death in hemodialysis patients.J Am Nephrol1991; 2: 335.
18.
FinkJ.C., CooperM.A., ZagerR.A.. Hemodialysis exacerbates enzymuria in patients with acute renal failure: Brief report.Ren Fail1996; 18: 947–50.
19.
CongerJ.D.. Does hemodialysis delay recovery from acute renal failure?Seminars in Dialysis1990; 3: 146–8.
20.
SolezK., Morel-MarogerL., SraerJ.D.. The morphology of “acute tubular necrosis” in man: Analysis of 57 renal biopsies and a comparison with glycerol model.Medicine1979; 58: 362–76.
21.
ArmstrongD., ReyburnH., JonesR.. A study of general practitioners’ reasons for changing their prescribing behaviour.Br Med J1996; 312: 949–52.
22.
CongerJ.D.. Interventions in clinical acute renal failure: What are the data?Am J Kidney Dis1995; 26: 565–76.
SchifflH., SitterT., LangS., KonigA., HaiderM., HeldE.. Bioincompatible membranes place patients with acute renal failure at increased risk of infection.ASAIO J1995; 41(3): M709–12.
25.
HakimR.M., Tolkoff-RubinN., HimmelfarbJ., WingardR.L., ParkerR.A.. A multicenter comparison of bioincompatible (BICM) and biocompatible (BCM) membranes in the treatment of acute renal failure (ARF).J Am Soc Nephrol1994; 5: 394 (abstract).
26.
HakimR.M., WingardR.L., ParkerR.A.. Effects of the dialysis membrane in the treatment of patients with acute renal failure.N Engl J Med1994; 331: 1338–42.
27.
KurtalH., von HerrathD., SchaeferK.. Is the choice of the membrane important for patients with acute renal failure requiring hemodialysis?Artif Organs1995; 19: 391–4.
28.
LianoF., PascalJ.. Group TMARFS. Epidemiology of acute renal failure: a prospective, multicenter community-based study.Kidney Int1996; 50: 811–18.
NeveuH., KleinknechtD., BrivetF., LoiratP., LandaisP.. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study.Nephrol Dial Transplant1996; 11: 293–9.
31.
GastaldelloK., MelotC., VanherweghemJ.L., KahnR.J., TielemannsC.. Cellulose diacetate (CDA) does as well as polysulfone for the treatment of acute renal failure (ARF) in the intensive care unit (ICU).J Am Soc Nephrol1996; 7: 1447 (abstract).
32.
AssouadM., TsengS., DunnK., GonzalezJ., BrennanS., SukiW.. Biocompatibility of dialyzer membranes is important in the outcome of acute renal failure.J Am Soc Nephrol1996; 7: 1437 (abstract).
33.
MehtaR., McDonaldB., GabbaiF.. Effect of biocompatible membranes on outcome from acute renal failure.J Am Soc Nephrol1996; 7: 1457 (abstract).
34.
SplendianiG., MioliV., AlbertazziA.. PAN versus cuprophan dialysis in the treatment of acute renal failure. In: ManNK M.C., HendersonL.W., ed. Blood purifications in perspective: new insights and future trends.Cleveland: ISAIO Press, 1987: 174–8.
35.
LevyE.. The effect of ARF on duration of hospitalization.J Am Soc Nephrol1996; 7: 1392 (abstract).
36.
HakimR.M.. Clinical implications of hemodialysis membrane biocompatibility.Kidney Int1993; 44: 484–94.
37.
SinclairD.G., HaslamP.L., QuinlanG.J., PepperJ.R., EvansT.W.. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability.Chest1995; 108(3): 718–24.
38.
Sunder PlassmannG., HorlW.H.. Can Hemodialysis technique modify the hypercatabolic state?Ren Fail1996; 18(3): 395–404.
39.
FeestT.G., RoundA., HamadS.. Incidence of severe acute renal failure in adults: Results of a community-based study.Br Med J1993; 306: 481–3.
40.
McGregorE., BrownJ., CampbellH.. Acute renal failure: A prospective study of incidence and outcome.Nephrol Dial Transplant1992; 7: J34 (abstract).
41.
JacobsC.. Membrane biocompatibility in the treatment of acute renal failure: What is the evidence in 1996?Nephrol Dial Transplant1997; 12: 38–42.
42.
MujaisS.K., IvanovichP., VidovichMlDialysis in acute renal failure: which membrane? (editorial).Artif Organs1994; 18(7): 470–2.
43.
MujaisS.K., IvanovichP., BerezaL.A., VidovichMlDialysis in acute renal failure-muddying the waters (editorial).ASAIO J1995; 41(2): 137–9.
44.
SchaeferK., von HerrathD.. Acute renal failure and membranes. Some medical and ethical questions (editorial).Int J Artif Organs1996; 19(3): 145–6.
45.
SchifflH.. Biocompatible membranes place patients with acute renal failure at increased risk of infection (Response).ASAIO J1996; 42(6): 1032–3.
46.
SchifflH.. Biocompatible membranes in acute renal failure (Letter).Lancet1996; 347: 205–6.
47.
ShaldonS.. Biocompatible membranes in acute renal failure: prospective case-controlled study (Letter).Nephrol Dial Transplant1997; 12: 235–6.
